Ministry of Food and Drug Safety (MFDS) โ Korea's Medical Device Regulator
Medical devices in South Korea are regulated by the Ministry of Food and Drug Safety (MFDS) under the Medical Device Act. All medical devices must be approved or certified by MFDS before commercial placement on the Korean market. Foreign manufacturers must appoint a locally licensed Korean importer or representative as the Marketing Authorization Holder (MAH) โ foreign entities cannot hold Korean medical device approvals directly.
Korea classifies medical devices into four classes (Class IโIV) based on risk. Class I devices require notification; Class II requires certification through a third-party accredited body; Class III and IV require full MFDS approval with clinical and technical review. Submissions are made via the SUGAM electronic portal. All approved manufacturers must maintain Korea Good Manufacturing Practice (KGMP) certification.
Korea's regulatory landscape is particularly significant for global manufacturers because it combines high regulatory standards with a world-class hospital infrastructure and sophisticated clinical buyer base. Korea is also a major medical device export hub โ many Korean manufacturers are expanding APAC-wide with JNPMEDI APAC as their Singapore-based regulatory partner.
- Korean-licensed MAH (importer) required โ foreign manufacturers cannot hold approvals directly
- KGMP certification required for all approved medical devices โ manufacturer site audit
- SUGAM portal used for all MFDS electronic submissions (Class IโIV)
- Post-market: adverse event reporting, periodic safety updates, re-examination for new devices
- NHI (National Health Insurance) listing required for reimbursed hospital procurement
Immediate Market Entry for Innovative Medical Technologies
Korea introduced a new immediate market entry pathway for qualifying innovative medical technologies, effective January 26, 2026. For eligible products, MFDS review timelines may be significantly reduced compared to the standard approval process.
Contact our Korea team. We assess your device class, existing approvals, and evidence package to determine whether the immediate entry pathway applies โ at no charge for an initial consultation.
MFDS Review Timelines by Device Class
Target review times from application submission โ KGMP audit scheduling runs in parallel.
Integrated Services for Korea MFDS Registration
MFDS Device Registration
End-to-end MFDS submission management for Class IโIV โ dossier preparation, SUGAM portal submission, KGMP audit coordination, deficiency response, and approval tracking. IVD and SaMD registration included.
Korean MAH & License Holding
JNPMEDI APAC coordinates Korean MAH appointment through our JNPMEDI Group Korea network โ providing a locally licensed MAH structurally independent from your distribution partners, protecting commercial flexibility throughout your Korea market presence.
Korea-to-APAC Platform
For Korean manufacturers, JNPMEDI APAC provides a direct bridge from Korean MFDS approval to APAC market access โ Singapore, Malaysia, Indonesia, Vietnam, Thailand, India, Taiwan, Japan, and beyond โ under a single integrated platform with shared dossier management.
Why JNPMEDI APAC for Korea MFDS Registration
JNPMEDI APAC is part of the JNPMEDI Group, headquartered in Korea. Our parent organization is one of Korea's leading regulatory affairs platforms โ with deep MFDS expertise, established SUGAM submission infrastructure, and direct relationships with Korean regulatory bodies. This gives JNPMEDI APAC unparalleled advantage for foreign manufacturers entering Korea and Korean manufacturers expanding into APAC.
In Korea, the MAH bears full regulatory responsibility and cannot be changed without re-submission. JNPMEDI APAC structures Korean MAH holding independently from your commercial distribution partner โ protecting your freedom to change distributors, enter new channels, or restructure commercial arrangements without triggering MFDS re-examination.
Korea is often the first Asia Pacific registration for global manufacturers โ but rarely the last. JNPMEDI APAC's integrated APAC platform means your Korea registration is the starting point for coordinated expansion into Singapore, Japan, Taiwan, ASEAN, and beyond โ with shared dossier management, single-vendor accountability, and regional regulatory strategy aligned from day one.
Korea MFDS Registration โ FAQ
Yes. MFDS requires a Korean-licensed importer or Marketing Authorization Holder to hold all Class IIโIV device approvals. Foreign manufacturers cannot hold Korean medical device approvals directly. JNPMEDI APAC coordinates MAH appointment through our JNPMEDI Korea Group network โ providing a locally licensed, independent MAH that is structurally separate from your distribution partners, protecting commercial flexibility.
Korea Good Manufacturing Practice (KGMP) is mandatory for all medical devices registered with MFDS. For foreign manufacturers, KGMP certification requires a manufacturing site audit by a MFDS-authorized auditor or accredited body. ISO 13485 certification is typically accepted as supporting evidence, but a dedicated KGMP audit is still required. JNPMEDI APAC coordinates KGMP audit scheduling and preparation as part of our Korea registration service.
SUGAM is MFDS's electronic submission platform for all medical device registration applications, post-approval variations, and safety reporting. All submissions, responses to MFDS queries, and approval certificates are managed through SUGAM. The portal requires Korean-language submissions in most cases, and the MAH account holder must be a Korean-registered entity. JNPMEDI APAC manages all SUGAM interactions on behalf of foreign manufacturers.
Yes โ with adaptation. MFDS technical files share significant structural overlap with PMDA (Japan) and TFDA (Taiwan) requirements, particularly in clinical evaluation, performance testing, and labelling. JNPMEDI APAC leverages MFDS-approved dossiers as the foundation for Japan and Taiwan submissions, substantially reducing preparation time and cost for Northeast Asia multi-market programs. Korea โ Japan โ Taiwan is one of our most efficient regional registration pathways.